Overview
- New advances in tuberculosis treatment, drug delivery, therapy and targeting
- Only publication with a roadmap for drug delivery that also covers clinical and medicinal aspects
- Covers nanoformulations and micro formulations
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
The book targets new advances in areas of treatment and drug delivery sciences for tuberculosis. It covers advances in drug therapy and drug targeting that focus on innovative trend defining technologies and drug delivery platforms in the understanding of host-pathogens relationship for providing better therapy. A wide variety of novel and nano-formulations using promising technologies are being explored to deliver the drug via different administration routes. This book It addresses the gap between new approaches and old treatment modalities and how they are superior in pharmacological performance when tested in in-vitro and in-vivo. Audience from wide range group like from researchers to regulatory bodies can benefit from the compiled information to find out patient needs and current research advances in the field of tuberculosis research.
.
.
Similar content being viewed by others
Keywords
Table of contents (16 chapters)
-
Front Matter
-
Back Matter
Editors and Affiliations
About the editors
Dr. Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Since last several years she is working with various multinational pharmaceutical companies at technical/R&D leadership roles. Currently, she serves as a Chief Scientific Officer, CapnoPharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and active targeting. Besides that, she edited many trending books on nanoparticles and their aspects. For her research, she received many prestigious national and international awards, among them the recent one is German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions for targeting various diseases and the role of excipients in developing the same.
Dr. Yashwant Pathak completed his Ph.D. in Pharmaceutical Technology from India and EMBA and MS Conflict Management from Sullivan University, USA. He is Associate Dean for Faculty Affairs College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia and industry, he has over 150 research publications, abstracts, chapters and reviews, 7 books in Nanotechnology and drug delivery systems, 6 in Nutraceuticals and several books in cultural studies. His areas of research include drug delivery systems, nanotechnology applications for pharmaceutical and Nutraceuticals. He has traveled extensively over 80 countries to network scientific experts and is actively involved with many Pharmacy colleges in different countries.
Bibliographic Information
Book Title: Tubercular Drug Delivery Systems
Book Subtitle: Advances in Treatment of Infectious Diseases
Editors: Ranjita Shegokar, Yashwant Pathak
DOI: https://doi.org/10.1007/978-3-031-14100-3
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
Hardcover ISBN: 978-3-031-14099-0Published: 15 March 2023
Softcover ISBN: 978-3-031-14102-7Published: 15 March 2024
eBook ISBN: 978-3-031-14100-3Published: 14 March 2023
Edition Number: 1
Number of Pages: X, 337
Number of Illustrations: 9 b/w illustrations, 42 illustrations in colour
Topics: Biotechnology, Medicine/Public Health, general, Pharmaceutical Sciences/Technology, Biomaterials